Report: Gamida cites success in leukemia PhIII


Globes is reporting that Gamida Cell completed a positive Phase III study if its stem cell treatment for leukemia and lymphoma. Investigators say that a preliminary analysis found that the therapy hit its primary outcome on the mortality rate. Secondary endpoints should be ready soon. Story